Page 2 - Director Mark Coleman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director mark coleman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Mark Coleman Today - Breaking & Trending Today

Axsome Therapeutics (NASDAQ:AXSM) Releases Earnings Results, Misses Estimates By $0.08 EPS

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) posted its earnings results on Monday. The company reported ($1.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.24) by ($0.08), MarketWatch Earnings reports. Axsome Therapeutics had a negative net margin of 101.07% and a negative return on equity of 92.39%. The firm had […] ....

United States , Mark Coleman , William Blair , Franklin Resources Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Topco Ltd , Securities Exchange Commission , Royal Bank , Axsome Therapeutics , Get Free Report , Marketwatch Earnings , Director Mark Coleman , Exchange Commission , Financial Advisors , Quantbot Technologies , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $102.40 Average Target Price from Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $102.40 Average Target Price from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , Piper Sandler , Mark Coleman , Axsome Therapeutics Inc , Commonwealth Equity Services , York Mellon Corp , Raymond James Financial Services Advisors Inc , Cantor Fitzgerald , Axsome Therapeutics , Get Free Report , Director Mark Coleman , Kantonalbank Zurich Cantonalbank , New York Mellon Corp , James Financial Services Advisors , Equity Services , Get Free , Axsome Therapeutics Daily ,

Axsome Therapeutics (NASDAQ:AXSM) Receives Buy Rating from Mizuho

Axsome Therapeutics (NASDAQ:AXSM) Receives Buy Rating from Mizuho
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , William Blair , Piper Sandler , Mark Coleman , China Universal Asset Management Co , Axsome Therapeutics Inc , Victory Capital Management Inc , Tower Research Capital , Securities Exchange Commission , Capital Management , Cantor Fitzgerald , Ameritas Investment Partners Inc , Axsome Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Mark Coleman , Exchange Commission , Universal Asset Management , Investment Partners , Research Capital , Victory Capital Management , Axsome Therapeutics Daily ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Baldwin Brothers LLC MA

Baldwin Brothers LLC MA lifted its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 47,995 shares of the company’s stock after acquiring an additional 500 shares during the quarter. […] ....

United States , William Blair , Piper Sandler , Mark Coleman , China Universal Asset Management Co , Tower Research Capital , Axsome Therapeutics Inc , Exchange Commission , Baldwin Brothers , Life Insurance Co , Axsome Therapeutics , Free Report , Financial Advisors , Universal Asset Management , Research Capital , Forest Capital Management , Metropolitan Life Insurance , Life Insurance , Director Mark Coleman , Get Free Report , Visit Holdingschannel , Axsome Therapeutics Daily , Nasdaq Axsm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,